Piramal Enterprises’ arm makes investment to expand US facility

21 Jun 2019 Evaluate

Piramal Pharma Solutions, the Contract Development and Manufacturing arm of Piramal Enterprises, has invested $10 million to expand its high-potency active pharmaceutical ingredients (HPAPIs) facility in the US. The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OEL).

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 956.85
Shriram Finance 967.00
Aditya Birla Capital 351.65
Chola Invest & Fin. 1714.90
Tata Capital 359.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×